Navigation Links
Wyeth's Motion to Overturn Punitive Damages Award Granted by Arkansas Court
Date:7/9/2008

- Appeal of Compensatory Award Will Now Proceed -

MADISON, N.J., July 9 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) confirmed today that its motion for judgment as a matter of law on the punitive damages award in the hormone therapy case of Donna Scroggin v. Wyeth, in the U.S. District Court, Eastern District of Arkansas, has been granted by the court. This ruling vacates the punitive damages award of $19,360,000 rendered by the Little Rock jury last year. The decision also clears the way for Wyeth to appeal the compensatory damages award of $2.75 million.

"We always believed there was no basis in fact or law for either award in this case," says Lyn P. Pruitt, an attorney with Mitchell, Williams, Selig, Gates & Woodyard, PLLC, a firm representing Wyeth. "We are pleased with the Court's decision vacating the punitive damages award and we look forward to presenting our arguments against the compensatory award to the Court of Appeals."

The court's ruling also vacates the $7,760,000 punitive damages award against co-defendant Upjohn.

The first phase of the trial began on February 5, 2008 before The Honorable William R. Wilson. The punitive damages phase began on March 3, 2008. The plaintiff alleged that she developed breast cancer from the use of Premarin(R) and Prempro(R), products marketed by Wyeth, as well as Provera, a product marketed by Upjohn.

Premarin (conjugated estrogens tablets USP) and Prempro (conjugated estrogens/medroxyprogesterone acetate tablets) are approved by the U.S. Food and Drug Administration as safe and effective when used as indicated.

About Wyeth

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a lead
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Fifth Annual Healthcare Unbound Conference to Focus on Remote Monitoring, Home Telehealth & eHealth for Disease Management & Wellness Promotion
2. Inclinix Expansion Creates New Position and Promotions
3. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
4. Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R)
5. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
6. Medivation Announces Senior Management Promotions
7. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
8. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
9. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
10. WaferGen Announces Management Team Promotions
11. Cadient Group Announces Recent Executive Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- Senomyx , Inc. (NASDAQ: SNMX ... discover, develop, and commercialize novel flavor ingredients, announced today ... Company,s Vice President, Biology and Gwen Rosenberg ... will present an overview of Senomyx,s technology and programs ... (7:25 a.m. Pacific Time) during the Citi 2013 Global ...
(Date:5/24/2013)... 24, 2013 Many factors impact tissues ... or efflux transporters at the blood-tissue barrier. Even when ... unbound fractions in the tissue rather than the total ... challenges is required to guide lead optimization, predict in ... species-dependent variables that may impact the likely human clinical ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Vestiage, ... lifestyle company focused on science-based research and development, ... anti-aging cosmeceuticals and nutraceuticals, announced today that it ... States for the sale of Reluma Skin Illuminating ... packet and application by sending an email to ...
(Date:5/23/2013)... , May 24, 2013 Die ... – Bei der englischen Version ... , 91 % der Teilnehmer einer groß angelegten Asthmaumfrage ... % laut GINA [*] -Definition [1] als kontrolliert ... mit Asthma generell einer von vier Denkweisen zugeordnet werden ...
Breaking Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7
... and Products Offset Patent Expirations, SAN FRANCISCO, ... of major neuropathic pain (NP) conditions is currently ... a report released today by,WWMR, Inc. Growth over ... by the,successful launch of Lyrica (pregabalin) for diabetic ...
... in Pharmaceutical Thin Film,Technology -, WARREN, N.J., ... specializing in quick dissolving thin film pharmaceutical products,today ... No. 7,425,292 from the,United States Patent and Trademark ... to issue on September 16, 2008, relates,to the ...
... 11 BioTrends Research Group, Inc. is,pleased to announce ... report in a series conducted with Anemia Managers. It ... by 150 Anemia Managers,-- 100 working with dialysis patients ... patients, and qualitative interviews with a,subset of 25 respondents. ...
Cached Biology Technology:US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 2US Neuropathic Pain Market Value Doubles to $5 Billion by 2018 3MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 2MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process 3New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 2New Study by BioTrends Highlights Anemia Practice Patterns According to Anemia Managers in Both Dialysis Units and CKD Clinics/Offices 3
(Date:5/22/2013)... to improve durability in fuel cell powered buses, ... discovered links between electrode degradation processes and bus ... effects of electrode degradation stressors in the operating ... , The findings of the study, led by ... in a long-term study at Burnaby-based Ballard Power ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
(Date:5/22/2013)... whole organism, as they may lead to life-threatening illnesses ... report how byproducts of respiration cause mispairing of subunits ... cells controls the form and function of every cell ... encoded in the linear sequence of the four subunits ... guanine (G) and thymine (T). Random changes in the ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2Fish oil may help the heart beat mental stress 2DNA damage: The dark side of respiration 2
... Des Moines, Iowa March 1, 2010 You ... three language-competent bonobos living at Great Ape Trust, than you ... day tell scientists more about the effect of culture on ... is a universal language, an alternative to spoken words to ...
... years on Down,s syndrome has focused on the DYRK1A ... the neurones, according to Mr Garikoitz Azkona. In his ... Down,s syndrome: the role of DYRK1A , Mr Azkona ... behind the problem that persons with Down,s syndrome have ...
... well known for keeping us healthy as it is for ... new research report appearing in the March 2010 print issue ... explain how they developed a genetically modified strain of tobacco ... scientifically known as microcystin-LR (MC-LR), which makes water unsafe for ...
Cached Biology News:If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 2If bonobo Kanzi can point as humans do, what other similarities can rearing reveal? 3DYRK1A gene may be 1 of most influential factors in Down syndrome 2
... SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit ... Catalog #9251, 200 ul SAPK/JNK (56G8) ... SAPK/JNK Cell Extracts, Catalog #9253, (4 ... Catalog #7074, 100 ul Anti-biotin IgG, ...
100 g monoclonal antibody which can immunocapture ~10 g of Complex IV from heart mitochondria. Also included are 2 mg of bovine heart mitochondria for control immunocapture....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Biology Products: